Hypothesis generating study to identify the changes in synovial tissue early after initiation of infliximab therapy
Latest Information Update: 09 Oct 2021
Price :
$35 *
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 20 Aug 2009 New source identified and integrated (Netherlands Trial Register, NTR1011).
- 26 Sep 2007 The expected completion date for this trial is now 1 Sep 2006.
- 21 Sep 2007 New trial record.